CPD Alert: Asthma Management Update 🫁

Date: Thursday, 11 June 2026
Focus: Pulmonary Speciality in Asthma Care

Topic: Access to Anti-inflammatory Inhalers for Everyone with Asthma — Still an Urgent Need

Join fellow clinicians for a focused CPD session on closing the gap in asthma care. We’ll cover:

1. Latest guidelines on inhaled corticosteroids + anti-inflammatory therapy
2. Barriers to access for patients and practical solutions
3. Case discussions from pulmonary specialists

Asthma affects millions, but access to proper anti-inflammatory inhalers remains a critical challenge. Let’s talk solutions.

Who should attend: Doctors, Physician Assistants, Nurses, Pharmacists, and other health care providers managing respiratory patients.

Management of Acute Asthma: Role of Ipratropium, Salbutamol, Hydrocortisone, and Aminophylline

Asthma is a chronic airway disease marked by bronchoconstriction, inflammation, and mucus production. Acute exacerbations require fast relief of symptoms and reduction of airway inflammation to prevent progression. Several medications are used together, each targeting a different part of the problem.

Click On The Link Below To Register and Participate.

https://us02web.zoom.us/meeting/register/KN9cIXdsSpaw6FE9RNoHlw

https://us02web.zoom.us/meeting/register/KN9cIXdsSpaw6FE9RNoHlw

https://us02web.zoom.us/meeting/register/KN9cIXdsSpaw6FE9RNoHlw

1. Salbutamol – First-line bronchodilator
Salbutamol is a short-acting beta-2 agonist, or SABA. It works within minutes by stimulating beta-2 receptors in airway smooth muscle, causing relaxation and rapid bronchodilation. Inhaled salbutamol is the cornerstone for relieving wheeze, shortness of breath, and chest tightness during an attack. It treats the symptom but has no anti-inflammatory effect.

2. Ipratropium Bromide – Add-on bronchodilator
Ipratropium is an anticholinergic. It blocks acetylcholine at muscarinic receptors, reducing vagally-mediated bronchoconstriction. It acts slower than salbutamol but lasts longer, about 4-6 hours. Guidelines recommend adding nebulized ipratropium to salbutamol in moderate-severe exacerbations because the combo produces greater and longer bronchodilation than either drug alone.

3. Hydrocortisone – Systemic anti-inflammatory
While bronchodilators open airways, hydrocortisone, a systemic corticosteroid, tackles the underlying inflammation. Given IV or orally in moderate-severe attacks, it reduces airway edema and mucus production over hours. Steroids don’t work immediately, so they’re started early to prevent relapse after the initial bronchodilation wears off. Inhaled corticosteroids play this role long-term, but hydrocortisone is used acutely when oral/IV therapy is needed.

4. Aminophylline – Reserve bronchodilator
Aminophylline is IV theophylline + ethylenediamine. It’s a methylxanthine that relaxes smooth muscle and has mild anti-inflammatory effects. Historically used for severe attacks not responding to SABAs + steroids. Today it’s a “reserve” drug because it has a narrow therapeutic window — blood levels must be monitored to avoid toxicity like arrhythmias and seizures. Most modern protocols prefer to optimize inhaled therapy before reaching for aminophylline.

Putting it together
In an acute asthma attack, management follows a stepwise approach:

1. Rapid bronchodilation with inhaled salbutamol, with ipratropium added if severity warrants.
2. Early systemic anti-inflammatory therapy with hydrocortisone to control inflammation.
3. Aminophylline considered only in severe, life-threatening cases under close monitoring when standard therapy fails.

This combination shows the dual goal of asthma care: relieve bronchospasm quickly, then control inflammation to keep the patient stable. Long-term management focuses on inhaled anti-inflammatory inhalers to reduce future attacks, which ties directly to your CPD topic on access to anti-inflammatory inhalers as an urgent need.

This is general educational information. Clinical decisions about dosing, route, and monitoring must be made by a qualified doctor based on the individual patient’s condition and guidelines.

Want me to condense this into bullet points for a slide you can use at the 11 June CPD?

DM us to register or for venue/details. Limited seats.

AsthmaCare #CPD #Pulmonology #BreatheBetter

---

Want me to make a shorter version for a WhatsApp status/poster, or add speaker names + venue once you have them?